Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could skipping pauses in CPR save more newborns? simulation study tests faster airway placement

NCT ID NCT07681960

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study tests whether a laryngeal mask airway (LMA) can be inserted during continuous chest compressions in a newborn resuscitation simulation. Standard guidelines recommend pausing compressions to insert an airway, but this interrupts blood flow. Thirty-two anesthesiologists will try inserting the LMA both with and without pausing chest compressions on a high-fidelity manikin to compare success rates, timing, and air leakage.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Size 1 ProSeal™ LMA
What this could lead to
If successful, this could change resuscitation guidelines to avoid pausing chest compressions, potentially improving outcomes for newborns.
What could go wrong
This is a small simulation study with 32 anesthesiologists using a manikin, not real patients. Results may not translate to actual clinical settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

32 people

The number who actually took part.

Started

Jun 2026

Finished

Jun 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Being a senior anesthesiology resident (completed 2nd year) or an attending anesthesiologist. 2. Voluntary participation with signed informed consent. Exclusion Criteria: 1. Refusal to participate. 2. Major physical disability that limits psychomotor tasks.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Airway management are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kahramanmaraş Sütçü İmam University, Faculty of Medicine

    Kahramanmaraş, Kahramanmaraş, 46100, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.